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Abstract. 
 
Adherent epithelial cells require interactions 
with the extracellular matrix for their survival, though 
the mechanism is ill-deﬁned. In long term cultures of 
primary mammary epithelial cells, a laminin-rich base-
ment membrane (BM) but not collagen I suppresses 
apoptosis, indicating that adhesion survival signals are 
speciﬁc in their response (Pullan et al. 1996. 
 
J
 
.
 
 Cell Sci
 
.
 
 
 
109:631–642). We now demonstrate that the signal from 
BM is mediated by integrins and requires both the 
 
a
 
6 
and 
 
b
 
1 subunits. In addition, a hormonal signal from in-
sulin or insulin-like growth factors, but not hydrocorti-
sone or prolactin, is necessary to suppress mammary 
cell apoptosis, indicating that BM and soluble factors 
cooperate in survival signaling. Insulin induced auto-
phosphorylation of its receptor whether mammary cells 
were cultured on collagen I or BM substrata. However, 
both the tyrosine phosphorylation of insulin receptor 
substrate-1 and its association with phosphatidylinosi-
tol 3-kinase were enhanced in cells cultured on BM, as 
was the phosphorylation of the phosphatidylinositol
3-kinase effector, protein kinase B. These results sug-
gest a novel extracellular matrix–dependent restriction 
point in insulin signaling in mammary epithelial cells. 
The proximal signal transduction event of insulin recep-
tor phosphorylation is not dependent on extracellular 
matrix, but the activation of downstream effectors re-
quires adhesion to BM. Since phosphatidylinositol
3-kinase was required for mammary epithelial cell sur-
vival, we propose that a possible mechanism for BM-
mediated suppression of apoptosis is through its facili-
tative effects on insulin signaling.
Key words: extracellular matrix • mammary gland • 
apoptosis • integrin • insulin
 
C
 
ELLS
 
 in multicellular organisms monitor their en-
vironment through interactions with neighbor-
ing cells and through receptors for both soluble
and locally acting factors including extracellular matrix
(ECM)
 
1
 
. In addition to providing signals for proliferation,
differentiation, and migration, such interactions are also
essential for survival and in their absence, cells undergo
apoptosis. While the cellular signaling pathways that con-
trol the decision to enter apoptosis are currently being
studied extensively, little is known about the interplay be-
tween survival factors derived from the soluble milieu and
the ECM.
The mammary gland is a particularly useful system to
study mechanisms that regulate apoptosis. Most of its epi-
thelial cells are removed by apoptosis during involution of
the gland after lactation, and the survival of purified mam-
mary epithelial cells can be manipulated in primary cul-
ture (Strange et al., 1992; Pullan et al., 1996). Several mod-
els have recently emerged to explain the post-lactational
induction of apoptosis. One possibility is that cessation of
suckling results in hormonal changes in the nursing mother
that alter the supply of soluble cell survival factors. As an
example of this, withdrawal of soluble survival factors such
as insulin or insulin-like growth factor I (IGF-I) from cul-
tured cells results in apoptosis (Rodriguez-Tarduchy et al.,
1992; Harrington et al., 1994; Parrizas et al., 1997). In the
mammary gland in vivo, the expression of an IGF-binding
protein which inhibits IGF action, IGFBP-5, is dramati-
cally increased after weaning and may therefore act to trig-
ger apoptosis (Tonner et al., 1997). Alternatively, expres-
sion of matrix-degrading metalloproteinases after weaning
may trigger cell death by breaking down cell–ECM interac-
tions (Talhouk et al., 1992; Alexander et al., 1996; Lund et
al., 1996). Although these hypotheses offer plausible ex-
planations for the induction of apoptosis in vivo, none
have been proven, suggesting that the mechanism may be
more easily deciphered using a cell culture model. How-
ever, even in cell cultures, very little is currently known
about the control of mammary epithelial apoptosis.
 
Address correspondence to Charles Streuli, School of Biological Sciences,
University of Manchester, 3.239 Stopford Building, Oxford Road,
Manchester M13 9PT, UK. Tel.: 44 161 275 5626. Fax: 44 161 275 7700.
E-mail: charles.streuli@man.ac.uk
 
1. 
 
Abbreviations used in this paper:
 
 BM, basement membrane; ECM, ex-
tracellular matrix; EHS, Engelbreth-Holm-Swarm tumor; IGF, insulin-
like growth factor; IRS, insulin receptor substrate; PI 3-kinase, phosphati-
dylinositol 3-kinase; PKB, protein kinase B. 
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Epithelial cells undergo apoptosis if they are denied
contact with ECM (Frisch and Francis, 1994; Khwaja et al.,
1997) and indeed, ECM is a survival factor in a number of
cell types (Frisch and Ruoslahti, 1997). The ECM is linked
to the cytoskeleton and to cytoplasmic signaling pathways
through integrins, and both integrins and some of their
downstream effectors, including p125FAK, are involved in
the survival response (Frisch et al., 1996). However, there
are very few natural situations where simple epithelial
cells are denied contact with the ECM for appreciable
periods of time, and we have therefore developed a
more physiological model than previously used to exam-
ine ECM survival signaling. Primary cultures of mouse
mammary epithelial cells and mammary cell lines show a
differential long term apoptotic response to different
ECM in tissue culture (Boudreau et al., 1995; Pullan et al.,
1996). On collagen I–coated substrata these cells form or-
ganized cobblestone monolayers, express E-cadherin and
desmocollins at their cell–cell junctions, and are polarized
(Streuli, 1995; Runswick et al., 1996). However, when cul-
tured on specialized ECM known as basement membrane
(BM), which contains laminin, collagen IV, nidogen and
perlecan, they develop into three-dimensional structures
which mimic alveoli in vivo (Aggeler et al., 1991). Al-
though in both situations they interact with the respective
substrata through integrins, cells cultured on collagen I
show extensive apoptosis over periods of several days
whereas those in contact with BM do not (Pullan et al.,
1996). Since mammary cells interact with collagen and BM
through different integrin receptors, it is likely that only
certain integrins deliver a survival signal (Howlett et al.,
1995; Metcalfe and Streuli, 1997).
Recent models for integrin-mediated control of pheno-
type in adherent cells have indicated that integrins might
cooperate with soluble factors to drive signaling pathways,
possibly through the formation of multi-protein adhesion
complexes (Miyamoto et al., 1996; Schneller et al., 1997).
Indeed, both proliferation and differentiation (Streuli et al.,
1995; Zhu et al., 1996) are dependent on ECM as well as
growth and differentiation factors. For example, cell an-
chorage regulates the activation of mitogen activated pro-
tein kinase by serum or EGF, and epithelial cell interac-
tions with BM are necessary for prolactin to trigger the
kinase Jak2 and activate the transcription factor Stat5 (Lin
et al., 1997; Renshaw et al., 1997; Edwards et al., 1998).
In this paper we have sought to determine whether solu-
ble factors and BM act coordinately to regulate the sup-
pression of apoptosis in primary cultures of mammary
epithelium. We show that insulin is an essential survival
ligand but that the cell–ECM interactions that lead to sur-
vival are necessary for insulin to trigger its downstream
survival signaling pathway.
 
Materials and Methods
 
Cell Culture
 
Primary mammary epithelial cells were prepared from 14.5–18.5-d preg-
nant ICR mice as previously described (Pullan et al., 1996). After culture
for 3 days, cells were trypsinized, passed through a 70-
 
m
 
m nylon mesh
(Falcon) to remove large cell aggregates, and plated at 1 
 
3
 
 10
 
5
 
 cells/cm
 
2
 
 in
DMEM/F12 medium containing 5% fetal calf serum (Advanced Protein
Products) and 5 ng/ml epidermal growth factor (Harlan Sera-Lab) over-
 
night, then washed and cultured in serum-free DMEM/F12 medium con-
taining appropriate combinations of 2.8 nM hydrocortisone, 880 nM insu-
lin, 150 nM prolactin (Sigma), with or without inhibitors of the insulin
signaling pathway. Some experiments included IGF-I or IGF-II (R&D
systems) in place of insulin.
The ECM substrata used for these studies were rat tail collagen I and
reconstituted BM matrix prepared from Engelbreth-Holm-Swarm (EHS)
tumor (Pullan and Streuli, 1996). Collagen I was coated onto tissue culture
plates overnight at 80 
 
m
 
g/ml and washed extensively before use, or in
some experiments commercially precoated Biocoat dishes were used
(Becton Dickinson). A factor-reduced preparation of the BM matrix was
prepared using sequential ammonium sulfate precipitations (Taub et al.,
1990) and coated onto tissue culture plastic at 14 mg/ml. In some experi-
ments, factor-reduced BM matrix was diluted into the culture medium (fi-
nal concentration 100 or 400 
 
m
 
g/ml) and overlaid onto first passage cells
plated on collagen I (Streuli et al., 1995).
 
Apoptosis Assays
 
To analyze DNA integrity, first passage cells were cultured in medium con-
taining appropriate hormones and inhibitors for two days, then washed
over a period of 2 h to remove the accumulated dead cells and debris. Fresh
medium was added to cells and after 4 h newly apoptotic cells were col-
lected from the medium and pooled with any remaining attached cells. DNA
was extracted from samples (Pullan et al., 1996), its OD was measured at
260 nm, and separated on a 1% agarose gel to confirm DNA loading after
staining the gel with ethidium bromide. Equal amounts of DNA were sep-
arated by conventional agarose gel electrophoresis, southern blotted, and
apoptotic DNA ladders were visualized by hybridization with a digoxige-
nin-labeled total mouse genomic DNA probe (Boehringer Mannheim).
Single cell cultures were prepared by straining first passage cells
through a 20-
 
m
 
m mesh, pelleting and resuspending in factor-reduced BM
matrix at 2–4
 
 3 
 
10
 
6
 
 cells/ml, as described (Streuli et al., 1991). 100 
 
m
 
l of
the mammary cell suspension was gelled for 60 min on dishes precoated
with a thin layer of BM, then cultured in serum-free DMEM/F12 medium
containing appropriate hormones, inhibitors or antibodies for 2 d before
fixation in 2% paraformaldehyde. 25-
 
m
 
m cryosections were stained with
0.5 
 
m
 
g/ml Hoechst 33258 and apoptotic nuclei were counted in the single
cell population. Each experiment was repeated two to three times and in
each experimental condition, 
 
.
 
600 single cells were scored for apoptosis.
Polyclonal rabbit anti–
 
b
 
1 integrin antibody was prepared in this labora-
tory (Edwards and Streuli, 1998). It was shown to inhibit the adhesion of
first passage mouse mammary epithelial cells to laminin, collagen IV, but
not fibronectin or vitronectin. Purified rat monoclonal antibody to 
 
a
 
6 in-
tegrin (GoH3) and its rat IgG2a isotype control were obtained from Sero-
tec. Rabbit polyclonal anti-laminin antibody was raised against purified
laminin isolated from EHS tumor (a kind gift of P. Yurchenco, Robert
Wood Johnson Medical School, Piscataway, NJ). This laminin had previ-
ously been shown to contain laminin A and B chains but not collagen IV
or nidogen (Streuli et al., 1995). A protein A–derived IgG fraction from
the rabbit serum was subsequently purified on an EHS affinity column.
This antibody significantly inhibited the adhesion of first passage mouse
mammary epithelial cells to laminin at 5 
 
m
 
g/ml and completely inhibited
adhesion at 30 
 
m
 
g/ml (data not shown).
A quantitative assay for apoptosis based on measuring cellular detach-
ment from different substrata was previously described (Pullan et al.,
1996). Cells detaching into the medium of first passage cultures over peri-
ods of 4 h were pelleted and counted using either a hemocytometer or a
Coulter counter. Detached cells were confirmed to have apoptotic mor-
phology by fluorescence microscopy after staining with 0.5 
 
m
 
g/ml Hoechst
33258, and the remaining monolayers were also stained with Hoechst
33258 to confirm that apoptotic cells did not accumulate there. Quantita-
tive data for detachment assays are all relative to the number of cells that
attached to each substrata after plating.
 
Protein Analysis
 
Mammary cells were cultured for 2 d, then washed and serum-free
DMEM/F12 medium with or without insulin was replaced for 15 min. The
cells were washed twice with 1 mM Na
 
3
 
VO
 
4
 
, 10 mM NaF in PBS and
scraped into NET lysis buffer (50 mM Tris-Cl, 150 mM NaCl, 1% NP-40,
2 mM EDTA, 10 mM NaF, 1 mM Na
 
3
 
VO
 
4
 
,
 
 
 
10 
 
m
 
g/ml aprotinin, 20 
 
m
 
M
leupeptin, 1 mM PMSF, pH 7.5). Cells were lysed by vortexing and then
rotating for 30–60 min at 4
 
8
 
C, and detergent insoluble proteins were
cleared by centrifugation at 7,000 
 
g
 
. Aliquots of samples were subjected to 
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SDS-PAGE on 6% gels, and the gels were stained with Coomassie Bril-
liant Blue to normalize protein levels. Equal amounts of protein were im-
munoprecipitated either with anti–IRS-1 antibody (UBI) or anti-insulin
receptor 
 
b
 
 antibody (Transduction Laboratories) and 20 
 
m
 
l protein
A–Sepharose beads (Zymed Laboratories), before being separated on 6%
gels under reducing conditions and transferred to Immobilon-P mem-
branes (Millipore). Phosphotyrosine blots were blocked in 1% BSA in
TBST, (50 mM Tris-Cl, 150 mM NaCl, 0.1% Tween 20, pH 7.5) and in-
cubated overnight with monoclonal antibody 4G10 (UBI) at 1:1,000 for
insulin receptor 
 
b
 
 or 1:3,000 for IRS-1. Interaction of the p85 subunit of PI
3-kinase with IRS-1 was examined by probing IRS-1 immunoblots with
anti–PI 3-kinase (UBI). For each experiment, equal amounts of protein
were confirmed for IRS-1 by blocking IRS-1 immunoblots in 3% nonfat
dry milk/PBS and probing with 1:3,000 anti–IRS-1 antibody; for insulin re-
ceptor 
 
b
 
, whole cell lysate blots were blocked with 3% BSA/TBST and
probed with 1:250 anti-insulin receptor 
 
b
 
. Protein kinase B (PKB, other-
wise known as c-Akt) was analyzed by immunoblotting equal amounts of
cell protein with either an anti-PKB antibody or an antibody specific for
phosphorylated PKB (both at 1:2,000; New England Biolabs). Proteins
were visualized by enhanced chemiluminescence (Amersham).
 
Results
 
Survival of Mammary Epithelium Is Regulated 
Coordinately by Insulin and BM
 
Mammary epithelial cells require appropriate cell–ECM
interactions for survival since they undergo apoptosis in
the absence of a BM (Pullan et al., 1996). To determine
the mechanism by which BM suppresses apoptosis, we
asked whether BM was able to act as a survival ligand by
itself or whether additional factors were required to pre-
vent cell death. First passage mammary epithelial cells iso-
lated from midpregnant mice were plated on substrata of
collagen I or a reconstituted BM matrix derived from the
EHS tumor. Culture on a BM matrix in the presence of
lactogenic hormones, insulin, prolactin, and hydrocorti-
sone, suppressed apoptosis, whereas cells died on collagen
I (Fig. 1 A). However, removal of lactogenic hormones
from the medium resulted in apoptotic death of the cells,
even those cultured on the BM matrix (Fig. 1 A). This in-
dicated that survival of mammary cells required two sig-
nals, one from the BM and a second signal from the hor-
monal milieu.
To determine which of the three hormones acted in a
survival capacity, cells plated on BM were incubated with
combinations of insulin, prolactin, and hydrocortisone and
the extent of cell death was measured by DNA fragmenta-
tion. Apoptosis occurred only when the cells were cultured
without insulin (Fig. 1 B). We also used an alternate assay
for apoptosis, where single mammary cells were cultured
within a BM gel, but apart from each other so that they
were unable to form cell–cell interactions (Streuli et al.,
1991). In this assay, apoptosis was measured by determin-
ing nuclear morphology after culture for 48 h (Fig. 1 C).
 
Figure 1
 
. Coordinate signaling between BM and insulin regulates
mammary survival. (A) Southern analysis of DNA isolated from
cells cultured on collagen I (CI) or BM in the presence (
 
1
 
) or ab-
sence (
 
2
 
) of insulin, prolactin and hydrocortisone (i, p, and h).
Note that DNA fragmentation is only suppressed in cells cul-
tured on BM together with lactogenic hormones. (B) Southern
analysis of DNA isolated from cells cultured on BM with combi-
nations of insulin, prolactin and hydrocortisone. Samples in lanes
2 and 7 were from cells cultured in phenol red–free media, and
the results indicate that estrogenic activity of phenol red did not
contribute to survival. (C) Cryosections of cells suspended within
gels of BM matrix after Hoechst staining (upper panels) and the
corresponding differential interference contrast images (lower
panels). These images are typical of apoptotic single cells cul-
tured with hydrocortisone and prolactin (p and h), and those
which resisted apoptosis when cultured additionally with insulin
(i, p, and h). (D) Quantitative analysis of apoptosis in single cells
embedded within BM. The percentage of apoptotic cells, as de-
termined by nuclear morphology after Hoechst staining, is shown
in cultures incubated with combinations of insulin, prolactin and
hydrocortisone. Results are the mean 
 
6 
 
SE of counts from five
independent cultures from two separate experiments. The values
with insulin are significantly different to those without insulin
(*
 
P
 
 , 
 
0.01). Less than 5% of the cells were apoptotic in embed-
ded cultures that were fixed 1 h after plating (T
 
o
 
). (E) Southern
analysis of DNA isolated from cells cultured on collagen I or BM
in the presence of 1, 10, or 100 nM IGF-I or IGF-II. Lanes 1–3
additionally contained prolactin and hydrocortisone (p and h).
(F) Quantitative analysis of IGF-I suppression of apoptosis in
single cells embedded within BM. Results are the mean 
 
6 
 
SE of
counts from six independent cultures from two separate experi-
ments. The values with insulin and IGF-I are significantly differ-
ent to those without hormones (*
 
P
 
 , 
 
0.05). Less than 5% of the
cells were apoptotic at the time of plating (T
 
o
 
). 
The Journal of Cell Biology, Volume 144, 1999 1340
 
when the anti-laminin antibody was included in the gel,
mammary cells underwent apoptosis even when they were
cultured in the presence of insulin. In contrast, an adhe-
sion-blocking antibody directed against fibronectin had no
effect (Fig. 3 A), neither did the inclusion of an RGD pep-
tide in the assay (Fig. 3 B). These results demonstrated
that within the context of a three-dimensional BM gel,
laminin has a survival-promoting function. Indeed, they
show that both insulin and laminin can act as survival
ligands for mammary epithelial cells, although they do not
rule out the possibility that other soluble factors or ECM
proteins may have a similar function.
 
BM Regulates Mammary Survival through 
 
a
 
6 and 
 
b
 
1 
Integrin Subunit
 
Major cellular receptors for BM proteins, including laminin,
are the transmembrane heterodimeric integrin receptors.
To confirm that BM acts directly to suppress apoptosis,
and that the survival signals were mediated by integrins,
we assessed whether function-blocking anti-integrin anti-
bodies interfered with the mammary cell survival using the
single cell assay. In experiments where an adhesion-block-
ing polyclonal anti–mouse 
 
b
 
1 integrin antibody was in-
cluded in the gel, insulin failed to suppress apoptosis. In-
deed, the levels of death were similar to those observed
in single mammary cells in the absence of insulin (Fig. 4 A).
One receptor for laminin is 
 
a
 
6
 
b
 
1 integrin, and we there-
fore performed parallel experiments using a function-
blocking anti–
 
a
 
6 integrin antibody (Fig. 4 B). The cellular
20–30% of single cells were apoptotic providing insulin
was present in the medium. However, in the absence of in-
sulin, cell death increased significantly (
 
P
 
 , 
 
0.01) to 60–
70% (Fig. 1 D). These two different approaches collec-
tively demonstrate that BM does not act alone to suppress
apoptosis in primary cultures of mammary epithelia. In-
stead, it regulates survival in combination with signals elic-
ited by insulin. Furthermore, the data show survival is not
dependent on mammary differentiation, since removal of
prolactin and hydrocortisone, which are required for milk
protein gene expression, did not result in apoptosis.
In addition to the ability of insulin to interact with its
own receptor, this hormone can also bind to the IGF re-
ceptor although with a 100–1,000-fold lower affinity (Par-
rizas et al., 1997). IGF-I or IGF-II have been shown to
act as survival factors in other cell types (Rodriguez-Tar-
duchy et al., 1992; Harrington et al., 1994; Kulik et al.,
1997), and we therefore tested whether they could directly
suppress mammary apoptosis. At physiological concentra-
tions, both IGF-I and IGF-II significantly inhibited the
DNA fragmentation exhibited by cells cultured on a BM
matrix in the absence of other hormones (Fig. 1 E). More-
over, IGF-I suppressed apoptosis (
 
P
 
 , 
 
0.01) in single
mammary cells cultured within the BM gel to the same ex-
tent as insulin (Fig. 1 F). The survival of mammary epithe-
lia can therefore be regulated by signals from IGF-I and
IGF-II in addition to those from insulin, and these signals
act coordinately with BM.
 
Laminin Is a Survival Ligand for Mammary
Epithelial Cells
 
Mammary epithelial cells plated onto a BM substratum
form multicellular, alveolar-like structures (Barcellos-Hoff
et al., 1989; Aggeler et al., 1991). Thus, it was important to
ask whether this complex three-dimensional structure was
involved with mammary cell survival, or if signals from the
BM–integrin interactions were sufficient. Therefore, we
cultured mammary cells as monolayers on collagen I and
incubated them with the EHS BM preparation diluted into
the culture medium. Under these conditions, the cells did
not form alveoli but remained as monolayers on the cul-
ture dish with some matrix proteins precipitating over the
cells (Streuli et al., 1995). Dilution of the BM preparation
140-fold to 0.1 mg/ml resulted in significant suppression of
apoptosis, both in a quantitative assay (Fig. 2 A) and in
DNA fragmentation studies (Fig. 2 B). BM proteins di-
luted 35-fold to 0.4 mg/ml suppressed apoptosis to virtu-
ally the same extent as in the cells cultured as alveoli on
top of a BM substratum (Fig. 2, A and B). Thus, the three-
dimensional multicellular structure is not a primary deter-
minant of mammary cell survival.
BM contains several ECM proteins and one component,
laminin, has previously been shown to be a survival ligand
for other cell types (Kim et al., 1994; Vachon et al., 1996;
Bozzo et al., 1997). To determine whether laminin was a
survival factor for mammary epithelial cells we developed
a function-blocking anti-laminin antibody that inhibited
adhesion of mammary cells to laminin (data not shown).
We assessed whether this antibody was able to interfere
with the survival of mammary cells that had been cultured
as single cells within BM gels (Fig. 3 A). We found that
Figure 2. Inhibition of mammary epithelial apoptosis by BM is
not dependent on three-dimensional multicellular structure.
Mammary cells cultured as monolayers on collagen I (0 mg/ml
EHS) were incubated with lactogenic hormones and the indi-
cated concentrations of BM proteins diluted into the culture me-
dium (0.1, 0.4 mg/ml EHS), or as alveoli on top of BM (14 mg/ml
EHS). (A) Apoptosis was measured in a quantitative assay. Each
day during a 3-d experiment, the cultures were washed and then
the detached apoptotic cells were collected over a 4-h time pe-
riod. Apoptosis is expressed as the number of apoptotic cells per
1,000 cells initially attached to the culture dish. Results are the
mean 6 SE of two separate experiments. The number of cells
that died toward the end of the experiment was lower than on
day 1 because at this time there were fewer cells remaining on the
dish. (B) Apoptosis was measured by DNA fragmentation analy-
sis as in Fig. 1 A. 
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response was similar to that for the anti–
 
b
 
1 integrin anti-
body, providing evidence that both the 
 
a
 
6 and 
 
b
 
1 integrin
subunits can transduce survival signals in normal mam-
mary epithelial cells. Suitable antibodies to other mouse
integrin subunits were not available to test for specificity.
Therefore, we performed similar experiments using func-
tion-blocking anti–human integrin antibodies and demon-
strated that 
 
a
 
6 and 
 
b
 
1 integrin, but not 
 
a
 
2 integrin, acts as
survival receptors in primary cultures of human mammary
cells (Oliver, J., M. O’Hare, and C.H. Streuli, manuscript
in preparation). In addition, our results with anti-fibronec-
tin antibodies and RGD peptides do not support a role for
 
a
 
v integrins in mammary cell survival.
Our combined data using function-blocking antibodies
to laminin and to integrin subunits show that suppression
of apoptosis in mammary epithelia depends on interac-
tions of the cells with BM through the 
 
a
 
6 and/or 
 
b
 
1 inte-
grin receptors, and that laminin can act as a survival
ligand.
 
BM and Insulin Regulate Survival in Mammary Cells by 
Cross Talk of Signaling Pathways
 
Since both insulin and laminin had been identified as
mammary cell survival factors, it is possible that they trig-
ger separate pathways required for suppressing apoptosis.
However, recent work on the control of cell cycle and
differentiation indicates that ECM affects the ability of
growth factors/cytokines to trigger their downstream sig-
naling kinases (Lin et al., 1997; Renshaw et al., 1997; Ed-
wards et al., 1998). Thus an alternative mechanism to
explain survival signaling in mammary cells is that the in-
sulin- and BM-triggered pathways converge. To determine
whether this was indeed the case, the extent of tyrosine
phosphorylation in the proximal components of the insulin
signaling pathway was measured (Fig. 5).
Insulin interacts with its receptor, causing receptor oli-
gomerization and activation of the kinase domain. This re-
sults in tyrosine phosphorylation of the receptor 
 
b
 
 subunit.
The adaptor protein insulin receptor substrate-1 (IRS-1) is
recruited to the insulin receptor, then becomes tyrosine
phosphorylated creating SH2 domain interaction sites for
downstream enzymes such as PI 3-kinase (Myers et al.,
1994; Sun et al., 1992). The ability of insulin to signal in
primary cultures of mammary cells plated on BM was
compared with those on collagen I. Tyrosine phosphoryla-
tion of the insulin receptor 
 
b
 
 subunit occurred within 15
min of insulin treatment and was independent of cell–
ECM interactions (Fig. 5 A). However, the ability of IRS-1
to become tyrosine phosphorylated in response to insulin
was strongly dependent on cell interactions with BM, and
virtually no IRS-1 phosphorylation was observed in cells
cultured on collagen I (Fig. 5 B).
It has been shown in several cell types that PI 3-kinase is
required for preventing apoptosis, and that in neuronal
cells and fibroblasts IGF-I suppresses apoptosis through
Figure 3. Laminin affects the survival poten-
tial of mammary epithelial cells. (A) Quanti-
tative analysis of apoptosis in single cells
embedded within BM in the presence of anti-
laminin and fibronectin antibodies. The per-
centage of apoptotic cells, as determined by
nuclear morphology after Hoechst staining, is
shown. Results are the mean 6 SE of counts
from four independent cultures from two sep-
arate experiments. The values with anti-lami-
nin antibody are significantly different to
those for control IgG and anti-fibronectin an-
tibody (P , 0.001). Note that insulin together
with prolactin and hydrocortisone failed to
suppress apoptosis in mammary cells cultured with anti-laminin antibody. (B) Quantitative analysis of apoptosis in single cells embed-
ded within BM in the presence of GRGDS and its control GRGES peptides. Note that there was no significant different difference in
levels of apoptosis between those cells cultured with and without GRGDS (P 5 0.34).
Figure 4. Requirement of integrin for mam-
mary cell survival. Quantitative analysis of
apoptosis in single cells embedded within BM
in the presence of anti-integrin antibodies.
The percentage of apoptotic cells, as deter-
mined by nuclear morphology after Hoechst
staining, is shown. Results are the mean 6 SE
of counts from five independent cultures from
two separate experiments. The values with
anti-integrin antibody are significantly differ-
ent to those for control IgG (*P , 0.05; **P ,
0.01). Insulin failed to suppress apoptosis in
mammary cells cultured with either (A) anti–
b1 integrin or (B) anti–a6 integrin antibody. 
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PI 3-kinase (Yao and Cooper, 1995; Minshall et al., 1996;
Dudek et al., 1997; Kennedy et al., 1997; Kulik et al., 1997;
Miller et al., 1997; Parrizas et al., 1997). PI 3-kinase is acti-
vated in response to insulin or IGF-I following the interac-
tion of its p85 subunit with IRS-1, and therefore we assessed
whether cell–ECM interactions regulated the association
of the p85 subunit of PI 3-kinase with IRS-1 (Myers et al.,
1994). PI 3-kinase did not associate with IRS-1 in mam-
mary cells cultured on either substratum in the absence of
insulin (Fig. 5 C). However, within 15 min of insulin treat-
ment PI 3-kinase bound IRS-1, but the extent of the inter-
action was strongly dependent on cell adhesion to BM;
quantitation of the data indicated that threefold more PI
3-kinase bound to IRS-1 in cells cultured on a BM substra-
tum than in cells cultured on collagen I (Fig. 5 D).
One downstream target of PI 3-kinase signaling path-
way is PKB, which has previously been implicated in the
suppression of apoptosis (Dudek et al., 1997; Kauffmann-
Zeh et al., 1997; Kulik et al., 1997; Crowder and Freeman,
1998). This enzyme is recruited to the plasma membrane
following PI 3-kinase phosphorylation of membrane lipids,
and then activated phosphorylation on serine/threonine
residues (Downward, 1998). Using an antibody specific for
phosphorylated PKB, we found that maximal activation
only occurred when mammary cells treated with insulin
had been cultured on BM (Fig. 6). Wortmannin com-
pletely abrogated insulin-induced PKB phosphorylation.
Since many of the assays to measure mammary apoptosis
in our work were carried out over several days, we also
measured PKB phosphorylation status in cells cultured
with insulin for 3 days. PKB was only phosphorylated in
cells cultured on BM, even though its level remained con-
stant whether the cells were on collagen I or BM substrata.
These results are an indirect confirmation that PI 3-kinase
activity depends on coordinate signals from insulin and
BM. Most importantly, they demonstrate that the PKB
pathway, already shown to be a critical determinant of sur-
vival in other cell systems, relies on converging insulin and
ECM signals in mammary epithelia.
Thus, the ECM dependence of insulin signaling corre-
lates with the ability of BM, but not collagen I, to deliver
survival cues.
 
Pharmacological Inhibitors of Enzymes in the PI
3-Kinase Signaling Pathway Induce Apoptosis of 
Mammary Epithelial Cells
 
The experiments described above suggested that the mech-
anism through which cell–ECM interactions regulate apop-
totic fate in mammary epithelial cells is through a control
on insulin-mediated PI 3-kinase signaling. To determine
whether the PI 3-kinase pathway, or related pathways,
were required for survival, the effects of the pharmacolog-
ical inhibitors LY 294002 and wortmannin were examined
in two independent assays for mammary apoptosis.
Mammary cells were cultured on a BM matrix with 10–
100 nM IGF-I, with or without 0.1 or 1 
 
m
 
M LY 294002. In
the absence of soluble factors the cells underwent apopto-
sis (Fig. 7 A, lane 2), and this was suppressed by IGF-I
(Fig. 7 A, lanes 3–6). However, IGF-I failed to suppress
apoptosis when LY 294002 was included in the cultures
(Fig. 7 A, lanes 7–10). We observed low levels of apoptosis
at 0.1 
 
m
 
M and very extensive DNA fragmentation at 1 
 
m
 
M
LY 294002, a concentration previously shown to inhibit
IGF-I signaling and PI 3-kinase activity (Vlahos et al.,
1994; Parrizas et al., 1997). Similar results were obtained
with wortmannin (data not shown).
The effect of the kinase inhibitors on suppression of
apoptosis by insulin was also examined in the single cell
assay. As before, mammary cells cultured within BM ma-
trix were not able to survive in the absence of insulin. Insu-
lin rescued the cells from apoptosis, but low levels of wort-
mannin (1 
 
m
 
M) and LY 294002 (0.1 
 
m
 
M) blocked survival
signaling (Fig. 7 B). The target specificity for wortmannin
Figure 5. Cross talk between insulin and BM signaling path-
ways. Mammary cells cultured on either collagen I or BM
were stimulated for 15 min with insulin or left unstimulated.
(A) Cell lysates were immunoprecipitated with anti-insulin
receptor b (Ins-Rb) antibody and precipitated proteins were
analyzed by immunoblotting for phosphotyrosine (4G10;
top). Equivalent amounts of insulin receptor b were con-
firmed by SDS-PAGE of the same amount of whole cell ly-
sate followed by immunoblotting with anti-insulin receptor
b antibody (bottom). (B) Duplicate cell lysates were immu-
noprecipitated with anti–IRS-1 antibody and precipitated
proteins were analyzed by immunoblotting for either phos-
photyrosine using 4G10 (top) or for IRS-1 itself to confirm
that equal levels of IRS-1 were present in all the samples
(bottom). (C) Association of PI 3-kinase with IRS-1 was de-
termined by immunoprecipitating lysates with anti–IRS-1
antibody, followed by immunoblotting with antibodies to ei-
ther phosphotyrosine, the p85 subunit of PI 3-kinase (p85),
or the precipitating antibody. (D) The signal from the exper-
iment in C was quantitated by scanning densitometry and
the level of phosphotyrosine or PI 3-kinase in each sample
was normalized to the level of IRS-1. Note that threefold
more PI 3-kinase associated with IRS-1 in cells cultured on
BM than in cells cultured on collagen I. 
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is fairly broad but includes PI 3-kinase whereas LY 294002
is specific for PI 3-kinase (Vlahos et al., 1994; Ui et al.,
1995). Thus, these two experiments indicate that the PI
3-kinase class of enzymes are necessary for mammary cell
survival.
Together our results suggest that mammary epithelial
cell survival depends upon a functional PI 3-kinase signal-
ing pathway which is normally triggered by insulin when
the cells are cultured with a BM substratum. Restricting
the activity of this pathway by culture on collagen I results
in cell death.
 
Discussion
 
The mechanisms that regulate death and survival decisions
in epithelial cells are not understood. Yet these are funda-
mental cellular processes and are essential not only for de-
ciphering the control of normal development, but also for
designing strategies to tackle progressive diseases such as
breast cancer.
In this study, we have addressed the mechanism whereby
BM suppresses apoptosis in primary cultures of mammary
epithelial cells and found that this type of ECM controls
the ability of insulin to deliver survival signals. We have
demonstrated that insulin is necessary to prevent death of
mammary cells through the PI 3-kinase pathway, and fur-
thermore that insulin-mediated interaction of PI 3-kinase
with IRS-1 and phosphorylation of PKB, a key enzyme
downstream in the PI 3-kinase pathway, is influenced by
cell interactions with BM. This provides new evidence for
the importance of ECM in the growth factor–mediated
regulation of cell phenotype. Since 
 
a
 
6 and 
 
b
 
1 integrins are
necessary for mammary cell survival, our work supports
the notion that one function of integrins is to regulate
growth factor signaling.
Figure 6. Phosphorylation of PKB is coordinately regulated by
insulin and BM. Mammary cells cultured on either collagen I or
BM were stimulated for 15 min with insulin or were left unstimu-
lated. Wortmannin was included in some cultures at the time of
insulin addition to show that PKB phosphorylation depended on
enzymes within the PI 3-kinase signaling pathway. Some cultures
were treated with insulin continuously for 3 d before harvesting.
(A) Cell lysates were analyzed by immunoblotting with an anti-
body specific for phospho-PKB (p-PKB; top). Equivalent
amounts of PKB were confirmed by reprobing the blots with
anti-PKB antibody (PKB; bottom). (B) The signal from the ex-
periment was quantitated by scanning densitometry and the level
of phosphorylation in each sample was normalized to the level of
PKB. Note that maximal phosphorylation depended on both in-
sulin treatment and the cells being in contact with BM, and that it
was inhibited by wortmannin.
Figure 7. Enzymes in the PI 3-kinase signaling pathway are re-
quired to suppress apoptosis of mammary epithelial cells. (A)
Southern analysis of DNA isolated from cells cultured on col-
lagen I, or on BM in the absence of factors or with IGF-I and the
kinase inhibitor LY 294002. Note the inability of IGF-1 to sup-
press apoptosis in the presence of PI 3-kinase inhibitor. Vehicle
alone (0.1% DMSO) did not itself induce DNA fragmentation
(lanes 5 and 6). (B) Quantitative analysis of apoptosis in single
cells embedded within BM in the presence of kinase inhibitors.
The percentage of apoptotic cells, as determined by nuclear mor-
phology after Hoechst staining, is shown. Results are the mean 6
SE of counts from four to six independent cultures from two sep-
arate experiments. The values with kinase inhibitors are signifi-
cantly different to those without (*P , 0.001). Note that insulin
failed to suppress apoptosis in mammary cells cultured with 1 mM
wortmannin or 0.1 mM LY 294002. 
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Two Signals Are Required for Survival of Mammary 
Epithelial Cells
 
Our previous studies, and those of others, have demon-
strated that mammary epithelial cells depend on BM for
survival (Boudreau et al., 1995; Pullan et al., 1996). We
have now found that they require a further signal from sol-
uble ligands to remain alive. Of three hormones tested, in-
sulin, but not hydrocortisone or prolactin, was found to be
necessary for suppression of apoptosis (Fig. 1). This sur-
vival effect of insulin could be mimicked by IGFs.
Insulin and IGFs have been shown to rescue apoptosis
in several cell lines following interleukin-3 or serum with-
drawal (Rodriguez-Tarduchy et al., 1992; Harrington et al.,
1994; Parrizas et al., 1997). However, although IGFs have
been proposed to act as survival factors in mammary
gland, this has not been demonstrated directly. For exam-
ple, overexpression of des(1-3)hIGF-I or IGF-I in mam-
mary glands of transgenic mice delayed involution and the
glands showed lower levels of apoptosis, but the target
cells were not identified (Hadsell et al., 1996; Neuen-
schwander et al., 1996). In the experiments performed in
our study, purified populations of mouse mammary epi-
thelial cells survived in the presence of insulin or IGFs, in-
dicating that the factors suppress apoptosis by a direct ac-
tion on the epithelial cells themselves.
Glucocorticoids have also been demonstrated to rescue
cells from apoptosis in the mammary gland, although it
was not determined whether the hormone acts directly on
epithelial cells or through an indirect mechanism (Feng et al.,
1995; Lund et al., 1996). In purified mammary epithelial
cells hydrocortisone had a minimal effect on survival, and
therefore its function in vivo would appear indirect. Thus,
although in vivo studies have indicated a role for both
IGFs and glucocorticoids in suppressing apoptosis in
mammary gland, our study with isolated cells shows that
only IGFs act directly on the epithelial cells themselves.
IGFs are normally only synthesized by stromal cells in the
mammary gland, but their expression is regulated by a syn-
ergy between growth hormone and estradiol (Yee et al.,
1989; Ruan et al., 1995). Therefore, one explanation for
the inhibition of apoptosis by hydrocortisone in vivo is
that this steroid can act on stromal cells to alter IGF ex-
pression. Alternatively, since IGFBP-5 has been suggested
to induce mammary involution, glucocorticoids may in-
hibit apoptosis in vivo by decreasing IGFBP-5 synthesis,
as occurs in cultured fibroblasts (Conover et al., 1995;
Tonner et al., 1997).
The ability of prolactin to suppress apoptosis directly
in purified mammary epithelial cells was also tested. In
agreement with previous studies which showed that pro-
lactin could not rescue mammary apoptosis in vivo, we
demonstrated that it also had a negligible effect on epithe-
lial cell survival in culture (Feng et al., 1995; Marti et al.,
1997). Prolactin regulates intracellular signaling through a
Jak/Stat pathway, which is required for mammary differ-
entiation. Although other cytokines have been proposed
to suppress apoptosis through Stat transcription factors, it
appears that this pathway is not directly involved in mam-
mary cell survival (Fujio et al., 1997).
Together our data show that, of the hormones tested, in-
sulin is sufficient for the survival of mammary cells cul-
tured on BM. Since prolactin and hydrocortisone, in addi-
tion to insulin, are necessary for lactation, the results
indicate that mammary cell survival does not depend on
differentiation. Moreover, as cells on collagen I undergo
apoptosis even in the presence of all three hormones, the
survival mechanism would appear to have more to do with
cell–ECM interactions than with differentiation.
 
Laminin Is a Survival Ligand for Mammary Cells
 
Cell–ECM interactions are known to suppress apoptosis in
epithelial cells (Meredith et al., 1993; Frisch and Francis,
1994; Khwaja et al., 1997). However, such studies are
based on comparing the survival potential of suspension-
cultured epithelial cell lines with those adhering to ECM
in short term assays. We have developed a model where
primary mammary cells isolated directly from tissue are
maintained on physiological substrata in longer term as-
says. These cells have not been selected for their ability to
form cell lines and therefore retain an apoptotic potential
that is as close as possible to that in vivo. They undergo
apoptosis specifically after culture for several days on tis-
sue culture plastic or collagen I, but not on BM (Pullan et
al., 1996). The cells plated on a BM substratum form mul-
ticellular structures resembling alveoli in vivo (Barcellos-
Hoff et al., 1989; Aggeler et al., 1991). However, this
three-dimensional architecture did not appear to play a
role in suppression of apoptosis (Fig. 2). Under conditions
where the cells remained as monolayers, apoptosis was ef-
ficiently suppressed by diluted BM proteins precipitating
over the cells.
Further verification that BM had a direct survival signal-
ing role came from studies using function-blocking anti-
bodies. Using a single cell assay developed previously for
analysis of differentiation (Streuli et al., 1991), we found
that although insulin was able to significantly suppress
apoptosis in cells cultured within a three-dimensional BM
gel, it was not able to do so if anti-laminin antibodies were
included (Fig. 3). Laminin has previously been shown to
act as a survival ligand for other cell lineages including fi-
brosarcoma and neuroblastoma cells and has been impli-
cated in preventing apoptosis during myogenesis (Kim et al.,
1994; Vachon et al., 1996; Bozzo et al., 1997; Vachon et al.,
1997). Our results extend these previous findings and show
that laminin also has a survival function in mammary epi-
thelium. However, laminin may not be a survival ligand
for all cells, since endothelial cells underwent apoptosis on
laminin substrata but not on fibronectin or vitronectin
(Wary et al., 1996). Thus, distinct cell types have a differ-
ent requirement for ECM to rescue them from apoptosis.
It remains to be determined whether or not the survival
response to different ECM ligands is mediated through
similar signaling pathways.
 
Integrins Are Survival Receptors in Mammary Cells
 
In several cell systems, integrins have been shown to be re-
quired for mediating a survival response (Frisch and Ruo-
slahti, 1997). We tested the possibility that integrins deliv-
ered survival signals in mammary cells by examining the
survival of single cells in BM gels after treatment with
function-blocking antibodies, and found that both 
 
a
 
6 and 
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b1 integrins were necessary to prevent the cells from
undergoing apoptosis. Although b1 integrins have been
shown to be required for mammary epithelial cell survival,
our results augment these studies by providing the first di-
rect evidence that a6 integrin functions in such a pathway
(Boudreau et al., 1995; Howlett et al., 1995; Fig. 4). These
findings have recently been confirmed in our experiments
with primary human breast epithelia, where anti–a6 and
anti–b1 integrin antibodies induced cell death, although
antibodies to the a2 subunit did not. The latter result indi-
cates a specificity of response as mammary cells express
significant levels of a2 integrin, but it also suggests that the
a2b1 integrin, a receptor for collagen, is not involved with
suppressing mammary apoptosis.
The b1 and b3 integrin subunits have previously been
shown to be survival receptors (Brooks et al., 1994; Bou-
dreau et al., 1995; Howlett et al., 1995; Zhang et al., 1995;
Scatena et al., 1998). RGD is a peptide substrate for avb3
integrin but we found that it had no effects on mammary
cell survival. Furthermore, in preliminary immunostaining
experiments with anti–av integrin antibodies, we have
only detected this subunit in the epithelial cells of virgin
mammary gland and it appeared to be completely absent
from pregnant and lactating tissue. Therefore, our data
would not support the possibility that it is a survival recep-
tor for mammary cells isolated from pregnant mammary
gland, even though it does have this role in endothelia
(Brooks et al., 1994; Scatena et al., 1998). In addition to
the b1 integrin subunit, mammary cells also express b4
integrin, and both of these can partner the a6 subunit.
Therefore, our data are not yet sufficient to confirm that
laminin suppresses apoptosis through a direct cell interac-
tion with the a6b1 integrin heterodimer, neither do they
exclude the possibility that other integrin subunits are in-
volved in survival. However, they do demonstrate that
laminin is a ligand for survival and that the a6 and b1 sub-
units can act as survival receptors.
The metastatic breast cancer cell line, MDA-MB-435
expresses a6b1 integrin. Tumors induced by a derivative
cell line in which a6b1 was functionally ablated were much
smaller those of the parental cells, and showed a sixfold
higher apoptotic/mitotic index (Wewer et al., 1997). These
results suggest that a6 integrin provides an anti-apoptotic
signal in vivo as well as in culture and together with the
present study, they may explain why higher levels of a6 in-
tegrin in human breast carcinomas correlate with an in-
creased likelihood of patient morbidity (Friedrichs et al.,
1995). Moreover, they suggest that a6 integrin–ligand in-
teractions might represent a target for therapeutic inter-
vention in breast disease, especially in combination with
agents which inhibit growth factor–mediated survival sig-
nals.
Receptor Cross Talk and the Control of Apoptosis
Since both BM and insulin were required for sustained
prevention of apoptosis in mammary cells, it was possible
that these ligands triggered either parallel or convergent
survival pathways. An abundance of studies indicate that
PI 3-kinase is essential for suppressing apoptosis in other
cell systems, possibly through PKB which has been impli-
cated as a downstream regulator of survival (Yao and
Cooper, 1995; Minshall et al., 1996; Dudek et al., 1997;
Kauffmann-Zeh et al., 1997; Kennedy et al., 1997; Khwaja
et al., 1997; Kulik et al., 1997; Parrizas et al., 1997; Crow-
der and Freeman, 1998). Our experiments using inhibi-
tors also demonstrated a requirement for PI 3-kinase in
mammary cell survival (Fig. 7). Therefore, we examined
whether this pathway was independently regulated by the
two separate ligands or if BM controlled the ability of in-
sulin to trigger its phosphorylation cascade, by measuring
the levels of phosphotyrosine in its proximal signaling pro-
teins.
Insulin rapidly induced tyrosine phosphorylation of its
receptor. However, the signaling events downstream of
the insulin receptor resulting in IRS-1 tyrosine phosphory-
lation and its association with PI 3-kinase were only prop-
agated in cells cultured on BM and not on collagen I (Fig.
5). These results contrast with a study using CHO cells
overexpressing insulin receptor, which showed that tran-
sient adhesion to fibronectin .20 min enhanced the insu-
lin-induced phosphorylation of both the receptor and IRS-1
(Guilherme et al., 1998). Our data support the conclusion
that ECM amplifies insulin signaling, but extends it by
showing that once nontransfected primary epithelial cells
have become established within an ECM environment
over several days, they develop a selective sensitivity to
growth factor signaling. Thus, the cellular environment de-
termines whether the insulin signal can be propagated effi-
ciently, and this only occurs when the cells contact a BM
but not when they are on collagen I. Indeed, the results in-
dicate the existence of an ECM-dependent restriction
point in insulin signaling, which occurs downstream of in-
sulin receptor phosphorylation.
The conclusion that BM and insulin cooperate to drive
insulin signaling was confirmed in further experiments
where we examined PKB phosphorylation, using both
short and long term treatments with insulin (Fig. 6). Cell–
matrix interactions had a similar effect of enhancing EGF
signaling in MDCK cells, although in that study the PKB
activation was examined in cells briefly attached to an
ECM in comparison with those detached from a substra-
tum (Khwaja et al., 1997). Together, these complementary
results indicate that both the short and long term activa-
tion of enzymes in the PI 3-kinase signaling pathway re-
quires adherent cells to be in the correct ECM microen-
vironment, which contributes to both EGF and insulin
signaling.
At the current time we do not know whether PKB is ab-
solutely required for mammary cell survival, but given the
results from other cell systems, this seems likely. Candi-
dates for the downstream link between PKB and the apop-
totic machinery include glycogen synthase kinase-3, pro-
caspase-9, and the pro-apoptotic protein Bad (Datta et al.,
1997; del Peso et al., 1997; Cardone et al., 1998; Pap and
Cooper, 1998). Although the phosphorylation of PKB and
Bad have been dissociated from each other, primary cul-
tures of mammary epithelial cells do express Bad, which
therefore remains a potential target for regulation by PKB
(Scheid and Duronio, 1998; our unpublished data).
Adhesion to ECM has previously been shown to sup-
press apoptosis in several cell types (Meredith et al., 1993;
Frisch and Francis, 1994; Kim et al., 1994; Vachon et al.,
1996; Wary et al., 1996; Bozzo et al., 1997; Khwaja et al.,The Journal of Cell Biology, Volume 144, 1999 1346
1997). In addition, cell–ECM interactions trigger integrin-
mediated downstream phosphorylation cascades involving
MAP kinase and PI 3-kinase, providing possible mecha-
nisms for ECM control of survival (Khwaja et al., 1997;
King et al., 1997; Lin et al., 1997). However, in the mam-
mary gland model we have now demonstrated that al-
though integrin signaling is necessary for survival, sus-
tained cell interactions with a BM substratum alone are
not sufficient to suppress apoptosis. In addition, insulin or
IGFs are also required. Similar conclusions have been
reached in studies of the cell cycle where serum factors
and ECM are both required for MAP kinase activation,
cyclin E–cdk2 activation, and retinoblastoma phosphory-
lation (Zhu et al., 1996; Renshaw et al., 1997). Dual signals
from soluble factors and ECM are also implicated in the
control of mammary differentiation, where prolactin and
BM are both necessary for triggering the prolactin signal-
ing cassette, Stat5 DNA binding, and milk protein gene
transcription (Streuli et al., 1995; Edwards et al., 1998).
Although our work shows that both laminin and insulin
act as survival ligands for mammary cells, we cannot rule
out the possibility that other types of ligand are important
in regulating survival. Insulin, for example, was only able
to suppress apoptosis of single mammary cells cultured
within BM by about twofold, suggesting that other factors
may play a role in mammary cell survival in vivo. Prelimi-
nary studies with primary cultures of human mammary ep-
ithelial cells, have demonstrated that apoptosis in the sin-
gle cell assay can be reduced by insulin, but is further
suppressed by EGF. But with mouse mammary cells, EGF
does not have an additional survival effect over and above
insulin (Oliver, J., and C.H. Streuli, unpublished data).
Therefore, it may be that additional cytokines can sup-
press apoptosis still further than insulin and BM in the
mouse system. Even if other mammary survival factors re-
main to be identified, our data are still sufficient to dem-
onstrate that both insulin and integrin contribute to the
survival of mammary cells.
In summary, these studies indicate that an important
function of cell–ECM interactions is to modulate growth
factor and cytokine responses. This suggests that current
thinking about growth factor signaling in adherent cells
should include a component from the ECM. One mecha-
nism might be via direct or indirect associations between
integrin and growth factor receptors, as has been demon-
strated for avb3 integrin and the insulin and PDGF recep-
tors, or with integrin and downstream components in the
insulin signaling pathway, as shown with avb3 integrin and
IRS-1 (Vuori and Ruoslahti, 1994; Schneller et al., 1997).
The role of integrins and the cytoskeleton in signal trans-
duction may be to provide a scaffold whereby components
of growth factors cassettes are assembled into discreet do-
mains within the cell, so that they can propagate signals ef-
ficiently. Indeed, a modular nature for membrane signal-
ing complexes has been proposed, which may explain the
recruitment of signaling proteins to cytoskeletal structures
such as adhesion plaques (Miyamoto et al., 1995; Plopper
et al., 1995; Pawson and Scott, 1997; Simons and Ikonen,
1997). Our current goal is to address this issue by deter-
mining whether the macromolecular organization of insu-
lin signaling proteins and integrins in mammary cells cul-
tured on BM are different to those in cells on collagen I.
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